Literature DB >> 23558211

Intra-lesional interferon injection for recurrent conjunctival MALT lymphoma.

M Zayed, K Sears, S M Salvi, P A Rundle, I G Rennie, H S Mudhar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23558211      PMCID： PMC3650287          DOI： 10.1038/eye.2013.46

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  5 in total

1.  Interferon treatment of childhood conjunctival lymphoma.

Authors:  R S Lucas; R Mortimore; T J Sullivan; M Waldie
Journal:  Br J Ophthalmol       Date:  2003-09       Impact factor: 4.638

2.  Local chemotherapy with interferon-alpha for conjunctival mucosa-associated lymphoid tissue lymphoma: a preliminary report.

Authors:  M A Blasi; F Gherlinzoni; G Calvisi; P Sasso; M Tani; M Cellini; E Balestrazzi
Journal:  Ophthalmology       Date:  2001-03       Impact factor: 12.079

3.  Intralesional interferon-α for conjunctival mucosa-associated lymphoid tissue lymphoma: long-term results.

Authors:  Maria Antonietta Blasi; Alessandra C Tiberti; Paola Valente; Michela Laguardia; Maria Grazia Sammarco; Angelo Balestrazzi; Luigi M Larocca; Emilio Balestrazzi
Journal:  Ophthalmology       Date:  2012-01-05       Impact factor: 12.079

4.  Interferon alpha in the therapy of conjunctival lymphoma in an HIV+ patient.

Authors:  M Cellini; G L Possati; P Puddu; R Caramazza
Journal:  Eur J Ophthalmol       Date:  1996 Oct-Dec       Impact factor: 1.922

5.  Ocular morbidity after radiotherapy of orbital and conjunctival lymphoma.

Authors:  E M Bessell; J M Henk; R A Whitelocke; J E Wright
Journal:  Eye (Lond)       Date:  1987       Impact factor: 3.775
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.